These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 8564232

  • 1. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.
    Yanai K, Ryu JH, Watanabe T, Iwata R, Ido T, Sawai Y, Ito K, Itoh M.
    Br J Pharmacol; 1995 Sep; 116(1):1649-55. PubMed ID: 8564232
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Positron emission tomographic study of central histamine H1-receptor occupancy in human subjects treated with epinastine, a second-generation antihistamine.
    Yanai K, Ryu JH, Watanabe T, Iwata R, Ido T, Asakura M, Matsumura R, Itoh M.
    Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():64-9. PubMed ID: 8750798
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.
    Tashiro M, Duan X, Kato M, Miyake M, Watanuki S, Ishikawa Y, Funaki Y, Iwata R, Itoh M, Yanai K.
    Br J Clin Pharmacol; 2008 Jun; 65(6):811-21. PubMed ID: 18410464
    [Abstract] [Full Text] [Related]

  • 6. Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography: comparison of H1 receptor occupancy and proportional impairment ratio.
    Kubo N, Senda M, Ohsumi Y, Sakamoto S, Matsumoto K, Tashiro M, Okamura N, Yanai K.
    Hum Psychopharmacol; 2011 Mar; 26(2):133-9. PubMed ID: 21433074
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.
    Tashiro M, Mochizuki H, Sakurada Y, Ishii K, Oda K, Kimura Y, Sasaki T, Ishiwata K, Yanai K.
    Br J Clin Pharmacol; 2006 Jan; 61(1):16-26. PubMed ID: 16390347
    [Abstract] [Full Text] [Related]

  • 10. Histamine H1 receptors in human brain visualized in vivo by [11C]doxepin and positron emission tomography.
    Yanai K, Watanabe T, Yokoyama H, Meguro K, Hatazawa J, Itoh M, Iwata R, Ishiwata K, Takahashi T, Ido T.
    Neurosci Lett; 1992 Mar 30; 137(2):145-8. PubMed ID: 1584454
    [Abstract] [Full Text] [Related]

  • 11. Histamine H1 receptor occupancy by the new-generation antipsychotics olanzapine and quetiapine: a positron emission tomography study in healthy volunteers.
    Sato H, Ito C, Hiraoka K, Tashiro M, Shibuya K, Funaki Y, Yoshikawa T, Iwata R, Matsuoka H, Yanai K.
    Psychopharmacology (Berl); 2015 Oct 30; 232(19):3497-505. PubMed ID: 26146015
    [Abstract] [Full Text] [Related]

  • 12. Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers.
    Farré M, Pérez-Mañá C, Papaseit E, Menoyo E, Pérez M, Martin S, Bullich S, Rojas S, Herance JR, Trampal C, Labeaga L, Valiente R.
    Br J Clin Pharmacol; 2014 Nov 30; 78(5):970-80. PubMed ID: 24833043
    [Abstract] [Full Text] [Related]

  • 13. [Functional neuropharmacology in the human brain using positron emission tomography: PET imaging of impaired cognitive performance induced by sedative antihistamines].
    Yanai K, Okamura N, Itoh M, Watanabe T.
    Nihon Yakurigaku Zasshi; 1998 Oct 30; 112 Suppl 1():48P-52P. PubMed ID: 10190133
    [Abstract] [Full Text] [Related]

  • 14. Dose dependency of brain histamine H(1) receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11C]doxepin.
    Tashiro M, Kato M, Miyake M, Watanuki S, Funaki Y, Ishikawa Y, Iwata R, Yanai K.
    Hum Psychopharmacol; 2009 Oct 30; 24(7):540-8. PubMed ID: 19697300
    [Abstract] [Full Text] [Related]

  • 15. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
    Leysen JE, Gommeren W, Janssen PF, Sanz G, Gillardin JM, Schotte A, Janssen PA.
    Allerg Immunol (Paris); 1991 Feb 30; 23(2):51-7. PubMed ID: 1677249
    [Abstract] [Full Text] [Related]

  • 16. Cerebral histamine H1 receptor binding potential measured with PET under a test dose of olopatadine, an antihistamine, is reduced after repeated administration of olopatadine.
    Senda M, Kubo N, Adachi K, Ikari Y, Matsumoto K, Shimizu K, Tominaga H.
    J Nucl Med; 2009 Jun 30; 50(6):887-92. PubMed ID: 19443589
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of in vivo selective binding of [11C]doxepin to histamine H1 receptors in five animal species.
    Ishiwata K, Kawamura K, Wang WF, Tsukada H, Harada N, Mochizuki H, Kimura Y, Ishii K, Iwata R, Yanai K.
    Nucl Med Biol; 2004 May 30; 31(4):493-502. PubMed ID: 15093820
    [Abstract] [Full Text] [Related]

  • 18. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.
    Malany S, Hernandez LM, Smith WF, Crowe PD, Hoare SR.
    J Recept Signal Transduct Res; 2009 May 30; 29(2):84-93. PubMed ID: 19308787
    [Abstract] [Full Text] [Related]

  • 19. Relationship between occupation of cerebral H1-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine.
    Rose C, Quach TT, Llorens C, Schwartz JC.
    Arzneimittelforschung; 1982 May 30; 32(9a):1171-3. PubMed ID: 6129863
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.